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Abstract  A  molecular  survey  was  conducted  in  Cochabamba,  Bolivia,  to  characterize  the
mechanism involved  in  the  resistance  to  clinically  relevant  antibiotics.  Extended  Spectrum
-lactamase encoding  genes  and  plasmid-mediated  quinolone  resistance  (PMQR)  markers  were
investigated in a  total  of  101 oxyimino-cephalosporin-resistant  enterobacteria  recovered  from
different  health  centers  during  four  months  (2012--2013).  CTX-M  enzymes  were  detected  in
all isolates,  being  the CTX-M-1  group  the  most  prevalent  (88.1%).  The  presence  of  blaOXA-1
was  detected  in 76.4%  of  these  isolates.  A high  quinolone  resistance  rate  was  observed  among
the included  isolates.  The  aac(6′)-Ib-cr  gene  was  the  most  frequent  PMQR  identified  (83.0%).
Furthermore,  6  isolates  harbored  the qnrB  gene.  Interestingly,  qepA1  (6) and  oqxAB  (1),  were
detected in 7  Escherichia  coli, being  the  latter the  first  to  be  reported  in Bolivia.  This  study  con-
stitutes the  first  molecular  survey  on resistance  markers  in clinical  enterobacterial  isolates  in
Cochabamba,  Bolivia,  contributing  to  the  regional  knowledge  of  the  epidemiological  situation.
The molecular  epidemiology  observed  herein  resembles  the scene  reported  in South  America.
© 2016  Asociacio´n  Argentina  de Microbiolog´ıa.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Primer  relevamiento  de marcadores  de  resistencia  a antibióticos  en
Enterobacteriaceae  en  Cochabamba,  Bolivia
Resumen  Se llevó  a  cabo  un  relevamiento  molecular  de  la  resistencia  a  antibióticos  de
importancia clínica  en  aislamientos  recuperados  en  Cochabamba,  Bolivia.  Se  estudiaron  los
genes codificantes  de  -lactamasas  de espectro  extendido  y  de  resistencia  a  quinolonas  de
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localización  plasmídica  (PMQR)  en  un  total  de 101 aislamientos  de  enterobacterias  resistentes  a
oximinocefalosporinas  recuperados  en  distintos  centros  de  salud,  durante  4  meses  (2012-2013).
En todos  ellos  se  detectó  la  presencia  de cefotaximasas,  las  CTX-M  grupo  1  fueron  las  más
prevalentes  (88,1%).  La  presencia  de blaOXA-1 se  detectó  en  el 76,4%  de  estos  aislamientos.
Se observó  una  elevada  proporción  de aislamientos  resistentes  a  quinolonas.  El gen  aac(6′)-Ib-
cr fue  el  determinante  PMQR  más  frecuentemente  identificado  (83%).  Además,  6 aislamientos
resultaron ser  portadores  de  qnrB. Por  otro  lado,  cabe  remarcar  que  7  Escherichia  coli  pre-
sentaron  qepA1  (6) y  oqxAB  (1);  se  documenta  así  por  primera  vez  la  presencia  de  oqxAB  en
Bolivia. Este  estudio  constituye  el  primer  relevamiento  de marcadores  de resistencia  en  ais-
lamientos clínicos  de  enterobacterias  en  Cochabamba,  Bolivia;  de este  modo  se  contribuye  al
conocimiento  regional  de  la  situación  epidemiológica,  la  cual  presenta  un  escenario  similar  al
observado en  el  resto  de  Latinoamérica.
©  2016  Asociacio´n  Argentina  de Microbiolog´ıa.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Antibiotic  resistance  is  one  of  the most  challenging
problems  in  modern  medicine  worldwide.  High  resistance
levels  are  observed  in Latin  America,  probably  due  to  the
widespread,  and  often  inappropriate,  use  of antibiotics
in  our  region,  resulting  in ineffective  treatments  which
enhance  morbidity  and  mortality  rates.
Third  generation  cephalosporins  (TGC)  and  quinolones
constitute  first  line  antibiotics  in enterobacterial  infec-
tions;  however  increasing  resistance  levels  are continuously
reported.  The  production  of  extended  spectrum  -
lactamases  (ESBL)  is  the most relevant  TGC  resistance
mechanism,  being  CTX-M-type  enzymes  prevalent  glob-
ally  (more  than  160  different  enzymes  have  already  been
reported  at  www.lahey.org/studies/).  CTX-M-enzymes  are
clustered  in  different  groups,  CTX-M-1  group,  CTX-M-2
group,  CTX-M-8  group,  CTX-M-9  group  and  CTX-M-25  group;
many  of  these  groups  include  different  allelic  variants.  CTX-
M-15,  corresponding  to  the  CTX-M-1  group  and  CTX-M-14,
belonging  to  the  CTX-M-9  group,  are by  far  the  most  clini-
cally  relevant  ESBL  worlwide3.
Spontaneous  chromosomal  mutations  in  gyrA  and parC,
within  the  quinolone  resistance-determining  region  (QRDR),
constitute  the main  mechanism  conferring  high  level
quinolone  resistance.  Plasmid-mediated  quinolone  resis-
tance  (PMQR)  determinants,  such  as  Qnr  proteins  (A,  B,  C, D
and  S),  Aac(6′)-Ib-cr  enzyme,  QepA  and OqxAB  efflux  pumps
are  increasingly  reported12.  Even  though  these  markers  only
provide  low  level quinolone  resistance  by  themselves,  it has
been  shown  that  they  facilitate  the  selection  of  chromo-
somal  mutations  in QRDR,  in vitro12.
No  surveillance  studies  on  resistance  markers  in clinical
isolates  have  been  previously  conducted  in Cochabamba,
Bolivia.  The  aim  of  this study  was  to  characterize  -lactam
and  quinolone  resistance  mechanisms  in  TGC  resistant
Enterobacteriaceae. Therefore,  a prospective,  observa-
tional,  descriptive  and transversal  study  was  carried  out.
All  cefotaxime  and/or  ceftazidime-resistant
Enterobacteriaceae  recovered  from  5 health  centers
in  Cochabamba,  Bolivia,  from  December  2012  to  March
2013  were  included.  Identification  was  performed  by
conventional  biochemical  tests.  Antimicrobial  susceptibility
profiles  were  determined  by  disk diffusion  and  agar  dilution
methods  in  accordance  with  CLSI,  2014.
Total  DNA was  obtained  by  boiling  bacterial  suspensions,
and  plasmid  DNA was  extracted  by  alkaline  lysis.  Screening
of  ESBL  coding  genes,  blaSHV,  blaCTX-M-1 group,  blaCTX-M-2
group,  blaCTX-M-8 group,  blaCTX-M-9 group,  blaCTX-M-25 group,
blaOXA-1,  blaOXA-2, blaOXA-10,  blaOXA-48, blaPER-2, blaKPC and
blaGES,  was  performed  by  simple  PCR  amplifications.  Primers
used  and the  expected  amplicon  sizes  are shown  in  a  sup-
plementary  table  (Table  S1).  Plasmid  encoded  ampC  genes8
and  Escherichia  coli  phylogenetic  groups4 were  determined
by  multiplex  PCR  as  previously  reported.
PMQR genes  (qepA,  oqxAB,  aac(6’)-Ib-cr,  qnr  (A,  B, C,
D,  S))  were  investigated  by  PCR  amplification  using  spe-
cific  primers9. Amplicons  identity  was  assessed  by  digestion
and/or  sequencing.  Nucleotide  sequences  were  compared
with  NCBI-BLAST  databases.  Statistical  analysis  was  per-
formed  using  the Fisher’s  exact  test  (SPSS  version  22).
Clonal  relatedness  was  analyzed  by REP/ERIC-PCR  and
dendrograms  were  constructed  using  the  Treecon  1.3b  pro-
gram.  Isolates  displaying  more  than  90%  identity  were
considered  to  be clonally  related.
A  total  of  101  TGC-resistant  enterobacteria,  correspond-
ing to  E.  coli  (87),  K.  pneumoniae  (11),  C.  freundii  (1),  M.
morganii  (1)  and  E.  cloacae  (1), were  recovered.  A  high
proportion  of the samples  (71.3%)  were  recovered  from
women  aged between  50  to  80  years  old.  Eighty  five  enter-
obacteria  (84.0%)  were  isolated  from  urine,  7 from  wound
secretions,  4  from  blood,  4  from  tracheal  secretions  and  the
remaining  from  ear secretions.  A  similar  distribution  was
observed  between  outpatients  and inpatients  (49.0%  and
51.0%,  respectively).
High resistance  rates to  nalidixic  acid, ciprofloxacin,
levofloxacin  and  gentamicin  were  observed.  Eighty  five  per-
cent  of  the isolates  were  not  susceptible  to  ceftazidime  and
90%  to  cefepime.  Resistance  to  cefoxitin,  kanamycin  and
amikacin  was  less  frequent  (Fig.  1).
MIC50 and  MIC90 values  were  as  follows:  cefotaxime
128  g/ml  and >128  g/ml, ceftazidime  16  g/ml  and
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Figure  1  Antimicrobial  susceptibility  profiles.  CTX,  cefo-
taxime;  CAZ:  ceftazidime,  FOX:  cefoxitin,  FEP:  cefepime,
NAL: nalidixic  acid,  CIP:  ciprofloxacin,  LEV:  levofloxacin,  KAN:
kanamycin,  GEN:  gentamicin,  AMI:  amikacin.
128  g/ml,  cefepime  8 g/ml  and  32  g/ml,  nalidixic  acid
>64  g/ml  and ciprofloxacin  >32  g/ml.
All  isolates  were  CTX-M  producers,  89/101  (88.1%)  har-
bored  blaCTX-M-1 group  markers  corresponding  to:  E.  coli (78),
K.  pneumoniae  (9),  E.  cloacae  (1)  and  M. morganii  (1).  Ten
isolates  carried  blaCTX-M-9 group  markers  belonging  to:  E.  coli
(9)  and  K. pneumoniae  (1).  The  only  C.  freundii  displayed
a  blaCTX-M-2 group  gene,  showing  a  very  low prevalence  of
this  marker.  Finally,  one  K.  pneumoniae  isolate  was  posi-
tive  for  both  blaCTX-M-1 and  blaCTX-M-9 group  markers.  In  good
agreement  with  the  South  American  scene,  a  radical  change
of  the  CTX-M-2  group  to CTX-M-1  and  CTX-M-9  groups  was
noted3,13,16.
Ten  randomly  selected  PCR  products  were  sequenced,
those  positive  for  the blaCTX-M-1 group  were  identified  as
blaCTX-M-15,  while  those  positive  for  the  blaCTX-M-9 group  cor-
responded  to  blaCTX-M-14. Neither  the  blaCTX-M-8 group  nor  the
blaCTX-M-25 group  were  detected.  In accordance  with  CLSI
breakpoints,  from  89  blaCTX-M-1 group-harboring  isolates,  62
(69.7%)  were  resistant  to  ceftazidime,  24  (27.0%)  were  cat-
egorized  as  intermediate  and  only  3  (3.3%)  were  categorized
as  susceptible.  Among  the blaCTX-M-9 group  positive  isolates,
8/10  were  categorized  as  susceptible  to  ceftazidime,  1  was
categorized  as  intermediate  and the remaining  as  resistant.
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Figure  2  Dendrogram  of  REP-PCR  profiles  of qepA-positive
isolates.  Sample  origin  ---- q1:  inpatient,  health  center  A,  urine
sample; q2:  outpatient,  health  center  A, urine  sample; q3: out-
patient,  health  center  B,  urine  sample; q4:  outpatient,  health
center  B,  urine  sample; q5: inpatient,  health  center  B,  secre-
tion; q6: inpatient,  health  center  C,  urine  sample.
C.  freundii  harboring  the  blaCTX-M-2 group  was  categorized  as
intermediate  to  this  agent.
A  blaOXA-1like  marker  was  detected  in 70/101  (69.3%)
ESBL-producing  isolates,  mainly  in  those  carrying  blaCTX-M-1
group  markers  (68/89,  76.4%).  Sequenced  amplicons
corresponded  100%  to  blaOXA-1. None  of  the blaCTX-M-9
group  positive  isolates  rendered  positive  amplification
for  blaOXA-1. The  association  of  blaCTX-M-1 group  markers
with  blaOXA-1 was confirmed  in this study  (p  < 0.001).  Nei-
ther  the  presence  of  plasmidic  AmpC  coding  genes  nor
blaOXA-2, blaOXA-10,  blaOXA-48,  blaPER-2,  blaKPC and blaGES were
detected.
Fifty  eight  from  87  E.  coli  isolates (67.0%)  belonged  to
phylogenetic  group  B2,  17.0%  to  group  A and  16.0%  to  group
D. The  CTX-M-1  group  producers  were  mostly  associated  with
the  phylogenetic  group B2  (p  < 0.01),  followed  by  A and  D.
CTX-M-9  group  producers  were mainly  associated  with  phy-
logenetic  group D,  followed  by  A and  B2.
Table  1  describes  the different  PMQR  detected  in this
study.  The  aac(6′)-Ib-cr  gene  was  present  in 83.0%  of the  iso-
lates,  being  the most prevalent  PMQR  determinant  among
the  studied  enterobacteria.  Other  less  common  markers
were  also  identified.  The  CTX-M-9  group  producers  did  not
harbor  any  of the analyzed  PMQR.
Among  Qnr  proteins,  only  qnrB  determinants  were
detected,  corresponding  to  qnrB1  (5)  and  qnrB19  (1).
Plasmid-mediated  efflux  pumps  were  identified  in 7 E.  coli
isolates  corresponding  to phylogenetic  group  B2.  A  sin-
gle  isolate  carried  oqxAB  while  the  other  6  harbored
qepA1.  The  latter  isolates  also  harbored  aac(6′)-Ib-cr
and  blaCTX-M-15, however  they  clustered  in three  different
groups  in accordance  with  REP-PCR  profiles  (Fig.  2). Each
Table  1  Main  features  of  the  PMQR  producing  enterobacterial  isolates.
PMQR  (n) Enterobacteriaceae  (n)  CTX-M  E.  coli  phylogenetic  group  (n)
aac(6′)-Ib-cr  (73)
E.  coli  (64)  CTX-M-1  group  B2  (48),  A  (9),  D  (7)
K. pneumoniae  (7)  CTX-M-1  group  --
M. morganii  (1)  CTX-M-1  group  --
C. freundii  (1) CTX-M-2  group  --
aac(6′)-Ib-cr  +  qepA1  (6) E.  coli  CTX-M-1  group  B2  (6)
aac(6′)-Ib-cr  +  qnrB1  (4) E.  coli  CTX-M-1  group  B2  (2),  A (1),  D (1)
aac(6′)-Ib-cr  +  qnrB19  (1) K.  pneumoniae  CTX-M-1  group  --
oqxAB (1)  E.  coli  CTX-M-1  group  B2  (1)
qnrB1 (1)  E.  cloacae  CTX-M-1  group  -
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cluster  contains  isolates collected  from  different  health
centers.
All  enterobacteria  included  in this study  were  ESBL  pro-
ducers,  corresponding  to  different  CTX-M  groups.  In  this
work,  CTX-M-1  group  enzymes  were  prevalent  in good agree-
ment  with  different  studies  conducted  by  Bartoloni  et al.
in  the  Bolivian  Chaco  (in  healthy  children  and  urinary  tract
infection  samples),  and  also  with  other  recent  studies  car-
ried  in  other  South  American  countries2,3,13,16.
Although  all  isolates  were  cefotaximase  producers,  10.9%
and  9.9%  were  categorized  as  susceptible  to  ceftazidime  in
accordance  with  the  current  breakpoints  of  the CLSI  and
EUCAST,  respectively.  Ceftazidime  susceptible  isolates  were
strongly  associated  with  the production  of CTX-M-9  group
ESBLs  (p  <  0.001).
Most  CTX-M-15-producing  E.  coli  belong  to phylogenetic
group  B2.  These  strains  display  a high  virulence  potential
and  have  been  mainly  associated  with  ST 131  constituting
a  major  public  health  problem  worldwide2,4,13,16.  Accord-
ingly,  in  this  study,  CTX-M-1  group  enzymes  were  strongly
associated  with  phylogroup  B2  (p  < 0.001).  However,  in
Venezuela  it  was  reported  that  phylogenetic  group  A was
prevalent  among  CTX-M-15-producing  uropathogenic  E.  coli
isolates6.
Different  PMQR  markers  were  identified,  with  aac(6′)-
Ib-cr  by  large  as  the  most  predominant.  This  variant  has
been  reported  in previous  studies  performed  in different
Latin  American  countries  such  as  Argentina,  Brazil,  Chile,
Mexico,  Peru  and  Uruguay5,9,14,16.  A  higher  aac(6′)-Ib-cr  rate
was  observed  in this  study  with  respect  to  previous  reports
in  Bolivia;  nevertheless  comparisons  between  these studies
should  be  performed  carefully  due  to  the different  bacterial
selection  criteria  used2.
Among  the  qnrB  genes  detected,  qnrB1  was  domi-
nant,  in  agreement  with  studies  conducted  in Mexico  and
Brazil14,15.  Moreover,  in previous  studies  conducted  in Bolivia
and  Argentina  qnrB19, qnrB10  and  qnrB2  genes7,9 were
reported.  To  the best  of  our  knowledge,  this constitutes  the
first  report  of  qnrB1  in Bolivia,  and  even  the description  of  its
association  with  aac(6′)-Ib-cr  and  blaCTX-M-1 group  resistance
determinants  in E. coli  isolated  from  clinical  samples.
There  are  few  reports  of  plasmid-mediated  fluoro-
quinolone  efflux  pumps  in Latin  America.  In  good  agreement
with  studies  performed  in Bolivia  and  Mexico,  qepA1  was
detected  in  CTX-M-15-producing  E.  coli isolates2,14.  The
qepA  gene  was  also  described  in  CTX-M-14  producing  E.  coli
clinical  isolates  in Peru,  and  in CTX-M-2  producing  E.  coli  in
Colombia  (Rincón  Cruz  G.,  PhD.  Thesis,  2015);  however,  in
Argentina  qepA1  was  found  in  non-ESBL  producing  E.  coli10.
Finally,  regarding  efflux  pump  OqxAB,  which is  uncommon
in  enterobacteria  other  than  K. pneumoniae, 1 isolate  of
E.  coli  carrying  oqxAB  was  identified,  being  the first  report
in  Bolivia  and one  of  the first  descriptions  in  Latin  America.
Recently  3oqxAB-  positive  E.  coli were  detected  in Peru  and
1  in Argentina1,11.
This  study  constitutes  the first  molecular  survey  on  -
lactam  and  quinolone  resistance  markers  in clinical  isolates
of  Enterobactericeae, in Cochabamba,  Bolivia.  These  results
contribute  to  the regional  knowledge  of the  epidemiolog-
ical  situation  regarding  the  resistance  to  frequently  used
antibiotics.  The  molecular  epidemiology  of  CTX-M-enzymes
and  its association  with  PMQR,  mainly  aac(6′)-Ib-cr;
observed  herein resembles  the scene  reported  recently  in
South  America.
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